Skip to content

To study the clinical curative effect of improved Valsalva on patients with orthostatic hypotension

To study the clinical curative effect of improved Valsalva on patients with orthostatic hypotension

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-12002515
Enrollment
Unknown
Registered
2012-09-12
Start date
2012-10-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

orthostatic hypotension

Interventions

1:Routine treatment + modified Valsalva action 50~60
Healthy control:Nill

Sponsors

Puai Hospital, Huazhong University of Science andTechnology Wuhan, Hubei, CHINA
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients are eligible if they have orthostatic hypotension,andno other causes of orthostatic hypotension.

Exclusion criteria

Exclusion criteria: Patients were excluded if they had other causes of orthostatic hypotension, could not give informed consent, had serious diseases or psychopath. Women who were pregnant, ready to pregnant, or breast-feeding a baby were excluded.

Design outcomes

Primary

MeasureTime frame
Blood pressur;

Countries

China

Contacts

Public ContactGu Ye
yegu2003cn@163.com+86 13707174353

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026